Logo image of MNRO

MONRO INC (MNRO) Stock Fundamental Analysis

USA - NASDAQ:MNRO - US6102361010 - Common Stock

18.53 USD
+0.04 (+0.22%)
Last: 10/3/2025, 8:00:01 PM
18.53 USD
0 (0%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to MNRO. MNRO was compared to 122 industry peers in the Specialty Retail industry. MNRO may be in some trouble as it scores bad on both profitability and health. MNRO is valued correctly, but it does not seem to be growing. MNRO also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MNRO was profitable.
MNRO had a positive operating cash flow in the past year.
Of the past 5 years MNRO 4 years were profitable.
In the past 5 years MNRO always reported a positive cash flow from operatings.
MNRO Yearly Net Income VS EBIT VS OCF VS FCFMNRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M

1.2 Ratios

MNRO's Return On Assets of -1.27% is in line compared to the rest of the industry. MNRO outperforms 40.16% of its industry peers.
The Return On Equity of MNRO (-3.38%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.27%
ROE -3.38%
ROIC N/A
ROA(3y)1.31%
ROA(5y)1.81%
ROE(3y)3.35%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
MNRO Yearly ROA, ROE, ROICMNRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10

1.3 Margins

MNRO's Operating Margin has declined in the last couple of years.
The Gross Margin of MNRO (34.52%) is comparable to the rest of the industry.
MNRO's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for MNRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.52%
OM growth 3Y-48.06%
OM growth 5Y-33.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-1.63%
MNRO Yearly Profit, Operating, Gross MarginsMNRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

3

2. Health

2.1 Basic Checks

MNRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MNRO remains at a similar level compared to 1 year ago.
The number of shares outstanding for MNRO has been reduced compared to 5 years ago.
The debt/assets ratio for MNRO has been reduced compared to a year ago.
MNRO Yearly Shares OutstandingMNRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
MNRO Yearly Total Debt VS Total AssetsMNRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

MNRO has an Altman-Z score of 1.40. This is a bad value and indicates that MNRO is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MNRO (1.40) is worse than 67.21% of its industry peers.
MNRO has a debt to FCF ratio of 4.03. This is a neutral value as MNRO would need 4.03 years to pay back of all of its debts.
The Debt to FCF ratio of MNRO (4.03) is better than 68.03% of its industry peers.
MNRO has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
MNRO's Debt to Equity ratio of 0.47 is in line compared to the rest of the industry. MNRO outperforms 52.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.03
Altman-Z 1.4
ROIC/WACCN/A
WACC8.92%
MNRO Yearly LT Debt VS Equity VS FCFMNRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

MNRO has a Current Ratio of 0.50. This is a bad value and indicates that MNRO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.50, MNRO is doing worse than 92.62% of the companies in the same industry.
MNRO has a Quick Ratio of 0.50. This is a bad value and indicates that MNRO is not financially healthy enough and could expect problems in meeting its short term obligations.
MNRO has a worse Quick ratio (0.16) than 92.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.5
Quick Ratio 0.16
MNRO Yearly Current Assets VS Current LiabilitesMNRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

3

3. Growth

3.1 Past

The earnings per share for MNRO have decreased strongly by -60.16% in the last year.
The earnings per share for MNRO have been decreasing by -23.90% on average. This is quite bad
Looking at the last year, MNRO shows a decrease in Revenue. The Revenue has decreased by -3.20% in the last year.
The Revenue has been decreasing by -0.99% on average over the past years.
EPS 1Y (TTM)-60.16%
EPS 3Y-35.89%
EPS 5Y-23.9%
EPS Q2Q%0%
Revenue 1Y (TTM)-3.2%
Revenue growth 3Y-4.19%
Revenue growth 5Y-0.99%
Sales Q2Q%2.68%

3.2 Future

MNRO is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.94% yearly.
The Revenue is expected to grow by 1.80% on average over the next years.
EPS Next Y28.44%
EPS Next 2Y31.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.58%
Revenue Next 2Y1.8%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MNRO Yearly Revenue VS EstimatesMNRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
MNRO Yearly EPS VS EstimatesMNRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

MNRO is valuated quite expensively with a Price/Earnings ratio of 37.82.
MNRO's Price/Earnings is on the same level as the industry average.
MNRO's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.86.
A Price/Forward Earnings ratio of 21.72 indicates a rather expensive valuation of MNRO.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MNRO is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.32, MNRO is valued at the same level.
Industry RankSector Rank
PE 37.82
Fwd PE 21.72
MNRO Price Earnings VS Forward Price EarningsMNRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

MNRO's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MNRO indicates a rather cheap valuation: MNRO is cheaper than 94.26% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.99
EV/EBITDA 14.34
MNRO Per share dataMNRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as MNRO's earnings are expected to grow with 31.94% in the coming years.
PEG (NY)1.33
PEG (5Y)N/A
EPS Next 2Y31.94%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.09%, MNRO is a good candidate for dividend investing.
MNRO's Dividend Yield is rather good when compared to the industry average which is at 5.56. MNRO pays more dividend than 95.08% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, MNRO pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.09%

5.2 History

The dividend of MNRO has a limited annual growth rate of 5.46%.
MNRO has been paying a dividend for at least 10 years, so it has a reliable track record.
MNRO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)5.46%
Div Incr Years0
Div Non Decr Years11
MNRO Yearly Dividends per shareMNRO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MNRO has negative earnings and hence a negative payout ratio. The dividend may be in danger.
MNRO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-170.7%
EPS Next 2Y31.94%
EPS Next 3YN/A
MNRO Yearly Income VS Free CF VS DividendMNRO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

MONRO INC

NASDAQ:MNRO (10/3/2025, 8:00:01 PM)

After market: 18.53 0 (0%)

18.53

+0.04 (+0.22%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners112.99%
Inst Owner Change3.94%
Ins Owners0.76%
Ins Owner Change6.86%
Market Cap555.53M
Analysts76.36
Price Target16.32 (-11.93%)
Short Float %18.82%
Short Ratio5.43
Dividend
Industry RankSector Rank
Dividend Yield 6.09%
Yearly Dividend1.17
Dividend Growth(5Y)5.46%
DP-170.7%
Div Incr Years0
Div Non Decr Years11
Ex-Date08-26 2025-08-26 (0.28)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-184.4%
Min EPS beat(2)-415.13%
Max EPS beat(2)46.33%
EPS beat(4)1
Avg EPS beat(4)-110.27%
Min EPS beat(4)-415.13%
Max EPS beat(4)46.33%
EPS beat(8)3
Avg EPS beat(8)377.49%
EPS beat(12)3
Avg EPS beat(12)243.06%
EPS beat(16)5
Avg EPS beat(16)180.56%
Revenue beat(2)0
Avg Revenue beat(2)-0.22%
Min Revenue beat(2)-0.34%
Max Revenue beat(2)-0.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.1%
Revenue beat(8)0
Avg Revenue beat(8)-2.67%
Revenue beat(12)0
Avg Revenue beat(12)-2.91%
Revenue beat(16)1
Avg Revenue beat(16)-2.29%
PT rev (1m)2.13%
PT rev (3m)-11.11%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-27.23%
EPS NY rev (1m)1.31%
EPS NY rev (3m)-15.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.61%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)1.83%
Valuation
Industry RankSector Rank
PE 37.82
Fwd PE 21.72
P/S 0.46
P/FCF 6.99
P/OCF 5.32
P/B 0.92
P/tB N/A
EV/EBITDA 14.34
EPS(TTM)0.49
EY2.64%
EPS(NY)0.85
Fwd EY4.6%
FCF(TTM)2.65
FCFY14.3%
OCF(TTM)3.48
OCFY18.78%
SpS40.13
BVpS20.18
TBVpS-4.71
PEG (NY)1.33
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.27%
ROE -3.38%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.52%
FCFM 6.6%
ROA(3y)1.31%
ROA(5y)1.81%
ROE(3y)3.35%
ROE(5y)4.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.3%
ROCE(5y)4.85%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-48.06%
OM growth 5Y-33.7%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.48%
GM growth 5Y-1.63%
F-Score4
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 4.03
Debt/EBITDA 4.66
Cap/Depr 37.01%
Cap/Sales 2.07%
Interest Coverage N/A
Cash Conversion 172.56%
Profit Quality N/A
Current Ratio 0.5
Quick Ratio 0.16
Altman-Z 1.4
F-Score4
WACC8.92%
ROIC/WACCN/A
Cap/Depr(3y)41.31%
Cap/Depr(5y)45.01%
Cap/Sales(3y)2.38%
Cap/Sales(5y)2.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.16%
EPS 3Y-35.89%
EPS 5Y-23.9%
EPS Q2Q%0%
EPS Next Y28.44%
EPS Next 2Y31.94%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.2%
Revenue growth 3Y-4.19%
Revenue growth 5Y-0.99%
Sales Q2Q%2.68%
Revenue Next Year0.58%
Revenue Next 2Y1.8%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-110.03%
EBIT growth 3Y-50.24%
EBIT growth 5Y-34.36%
EBIT Next Year143.2%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-53.54%
FCF growth 3Y-10.25%
FCF growth 5Y10.05%
OCF growth 1Y-50.2%
OCF growth 3Y-8.78%
OCF growth 5Y1.69%